Reassessing vascular endothelial growth factor (VEGF) in anti-angiogenic cancer therapy

Reassessing vascular endothelial growth factor (VEGF) in anti-angiogenic cancer therapy

Vascularization is fundamental to the growth and spread of tumor cells to distant sites. As a consequence, angiogenesis, the sprouting of new blood vessels from existing ones, is a characteristic trait of cancer. In 1971, Judah Folkman postulated that tumour growth is angiogenesis dependent and that...

Full description

Bibliographic Details
Main Authors: Tobiloba C. Elebiyo, Damilare Rotimi, Ikponmwosa O. Evbuomwan, Rotdelmwa Filibus Maimako, Matthew Iyobhebhe, Oluwafemi Adeleke Ojo, Olarewaju M. Oluba, Oluyomi S. Adeyemi
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Cancer Treatment and Research Communications
Subjects:
Cancer
Tumour blood vessels
Angiogenesis
Vascular endothelial growth factor (VEGF)
Anti-angiogenic therapy
Vascular normalization therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2468294222001113

Internet

http://www.sciencedirect.com/science/article/pii/S2468294222001113

Similar Items